Clinical Trials

New Search
Title   A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine (Advance)
Disease/Condition   Brain and Neurological,Headache,Migraine,Nervous System Diseases
Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Richard Bruce Lipton, MD
Contact Name   Daniel Sun
Contact Email
IRB/Protocol Number   18-02-320-01
Status   Active/Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No
Sub-Specialty   Neurophysiology - Migraine
Minimum Age   0
Maximum Age   0